Improved Urothelial Cell Proliferation, Cytoskeleton and Barrier Function Protein Expression in the Patients With Interstitial Cystitis/Bladder Pain Syndrome After Intravesical Platelet-Rich Plasma Injection

被引:0
|
作者
Jhang, Jia-Fong [1 ]
Jiang, Yuan-Hong [1 ]
Hsu, Yung-Hsiang [2 ]
Ho, Han-Chen [3 ]
Birder, Lori A. [4 ,5 ,6 ]
Lin, Teng-Yi [7 ,8 ]
Kuo, Hann-Chorng [1 ]
机构
[1] Tzu Chi Univ, Hualien Tzu Chi Hosp, Tzu Chi Med Fdn, Dept Urol, Hualien, Taiwan
[2] Tzu Chi Univ, Hualien Tzu Chi Hosp, Tzu Chi Med Fdn, Dept Pathol, Hualien, Taiwan
[3] Tzu Chi Univ, Dept Anat, Hualien, Taiwan
[4] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
[5] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA
[6] Univ Pittsburgh, Dept Chem Biol, Pittsburgh, PA USA
[7] Buddhist Tzu Chi Univ, Hualien Tzu Chi Hosp, Dept Lab Med, Hualien, Taiwan
[8] Buddhist Tzu Chi Univ, Buddhist Tzu Chi Med Fdn, Hualien, Taiwan
关键词
Urothelium; Pathogenesis; Human; Platelet; Bladder; ABNORMAL EXPRESSION; STEM-CELLS; BLADDER; DIFFERENTIATION;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To investigate urothelial cell proliferation, cytoskeleton, inflammation, and barrier function protein expressions in patients with interstitial cystitis/bladder pain syndrome (IC/BPS) after intravesical platelet-rich plasma (PRP) injections. Methods: A total of 19 patients with IC/BPS underwent 4 monthly intravesical PRP injections. Bladder biopsies were taken at the first and fourth PRP treatment. The bladder specimens were analyzed using the Western blot and immunochemical staining for progenitor cell markers for sonic hedgehog (Shh), CD34, and cytoskeleton proteins cytokeratin 5 (CK5), CK14, CK20; barrier function markers for zonula occludens-1 (ZO-1), E-cadherin, and intercellular adhesive molecule-1, tryptase and transforming growth factor-beta (TGF-beta). Global response assessment (GRA) was used to evaluate treatment outcomes. Results: The mean age of patients was 55.6 years. After PRP injections, the functional bladder capacity and maximum flow rate increased, and the visual analogue scale (VAS) of pain, interstitial cystitis (IC) symptom index, IC problem index, O'Leary-Sant symptom score, and GRA improved in all patients. Urothelium Shh, CK5, ZO-1, E-cadherin, and TGF-beta expressions increased significantly after repeated PRP injections. By subgrouping, according to PRP treatment outcomes, significant increases in Shh, E-cadherin, and ZO-1 expressions were noted only in patients with GRA >= 1 or improved VAS, but not in patients with GRA = 0 and no improvement in VAS. Conclusions: The level of urothelial barrier function protein and cell proliferation protein expression in the patients with IC/BPS was increased after repeat intravesical PRP injections. Intravesical repeat PRP injections may have potential to improve urothelial health and result in symptoms improvement in the patients with IC/BPS.
引用
收藏
页码:S57 / S67
页数:11
相关论文
共 50 条
  • [21] Platelet-Rich Plasma Ameliorates Cyclophosphamide-Induced Acute Interstitial Cystitis/Painful Bladder Syndrome in a Rat Model
    Chen, Yung-Hsiang
    Man, Kee-Ming
    Chen, Wen-Chi
    Liu, Po-Len
    Tsai, Kao-Sung
    Tsai, Ming-Yen
    Wu, Yu-Tzu
    Chen, Huey-Yi
    DIAGNOSTICS, 2020, 10 (06)
  • [22] Repeated intravesical injections of platelet-rich plasma improve symptoms and alter urinary functional proteins in patients with refractory interstitial cystitis
    Jiang, Yuan-Hong
    Kuo, Yuh-Chen
    Jhang, Jia-Fong
    Lee, Cheng-Ling
    Hsu, Yung-Hsiang
    Ho, Han-Chen
    Kuo, Hann-Chorng
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [23] Repeated intravesical injections of platelet-rich plasma improve symptoms and alter urinary functional proteins in patients with refractory interstitial cystitis
    Yuan-Hong Jiang
    Yuh-Chen Kuo
    Jia-Fong Jhang
    Cheng-Ling Lee
    Yung-Hsiang Hsu
    Han-Chen Ho
    Hann-Chorng Kuo
    Scientific Reports, 10
  • [24] PREDICTIVE FACTORS FOR A SUCCESSFUL TREATMENT OUTCOME OF INTRAVESICAL BOTULINUM TOXIN A INJECTION FOR PATIENTS WITH INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME
    Wang, Hsiu-Jen
    Kuo, Hann-Chorng
    JOURNAL OF UROLOGY, 2020, 203 : E534 - E535
  • [25] Predictive Factors for a Satisfactory Treatment Outcome with Intravesical Botulinum Toxin A Injection in Patients with Interstitial Cystitis/Bladder Pain Syndrome
    Wang, Hsiu-Jen
    Yu, Wan-Ru
    Ong, Hueih-Ling
    Kuo, Hann-Chorng
    TOXINS, 2019, 11 (11)
  • [26] New Frontiers or the Treatment of Interstitial Cystitis/Bladder Pain Syndrome - Focused on Stem Cells, Platelet-Rich Plasma, and Low-Energy Shock Wave
    Lin, Chih-Chieh
    Huang, Yun-Ching
    Lee, Wei-Chia
    Chuang, Yao-Chi
    INTERNATIONAL NEUROUROLOGY JOURNAL, 2020, 24 (03) : 211 - 221
  • [27] The Tumor Necrosis Factor-α Level in Platelet-Rich Plasma Might Be Associated with Treatment Outcome in Patients with Interstitial Cystitis/Bladder Pain Syndrome or Recurrent Urinary Tract Infection
    Jhang, Jia-Fong
    Jiang, Yuan-Hong
    Lin, Teng-Yi
    Kuo, Hann-Chorng
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (01)
  • [28] Smoking-induced urothelial cell accumulation of platelet-activating factor: Implications for interstitial cystitis/bladder pain syndrome
    McHowat, Jane
    Marentette, John
    Isbell, T. Scott
    Campian, E. Cristian
    FASEB JOURNAL, 2016, 30
  • [29] Changes in Sexual Function of Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome after Intravesical Therapy with a Hyaluronic Acid Solution
    Hung, Man-Jung
    Su, Tsung-Hsien
    Lin, Yi-Hao
    Huang, Wen-Chu
    Lin, Tzu-Yin
    Hsu, Chun-Shuo
    Chuang, Fei-Chi
    Tsai, Ching-Pei
    Shen, Pao-Sheng
    Chen, Gin-Den
    JOURNAL OF SEXUAL MEDICINE, 2014, 11 (09): : 2256 - 2263
  • [30] THE UROTHELIAL NEUROTROPHIN AND THEIR RECEPTORS EXPRESSION IN PATIENTS OF INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME WITH DIFFERENT CLINICAL PHENOTYPES AND SYMPTOM SEVERITY
    Jhang, Jia-Fong
    Ho, Han-Chen
    Jiang, Yuan-Hong
    Hsu, Yung-Hsiang
    Kuo, Hann-Chorng
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1055 - E1056